New

Tuberculosis Infection Testing Market

2021

Tuberculosis Infection Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA), Others); End Use (Hospitals and Clinics, Diagnostic Laboratories, and Others), and Geography

| Report Code: TIPRE00024196 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Tuberculosis Infection Testing Market 2028 By Type, End Use, and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Tuberculosis is an infectious disease with mycobacteria its primary cause. In general, tuberculosis attacks the lungs or even other parts of the body such as the genitourinary system, lymphatic system, and central nervous system. Tuberculosis affected in the lungs is known as Pulmonary Tuberculosis, while effects in other parts of the body are known as extrapulmonary Tuberculosis. It can be proliferated through the air by cough, sneeze or transmit through air. The significant symptoms of tuberculosis are chronic cough, night sweat, blood-tinged sputum, and fever.

MARKET SCOPE

The "Global Tuberculosis Infection Testing Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Tuberculosis infection testing market with detailed market segmentation by type, end use, and geography. The report provides key statistics on the market status of the leading Tuberculosis infection testing market players and offers key trends and opportunities in the market.MARKET SEGMENTATION

  •  Based on type, the global Tuberculosis infection testing market is segmented into tuberculin skin test (tst), interferon gamma released assay (igra), others.
  •  On the basis of end use, the market is segmented into hospitals and clinics, diagnostic laboratories, others.

MARKET DYNAMICS
Drivers:

  •  Rise in the cigarette consumption.
  •  Growing awareness regarding tuberculosis.
  •  Rise in geriatric population.
  •  Rising cases of HIV.
  •  Growth in Pharmaceutical Research and Development.

Restraints:

  •  The multidrug resistant tuberculosis and stringent regulation are the major restraining factor for this market.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Tuberculosis infection testing market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Tuberculosis infection testing market in these regions.

IMPACT OF COVID-19 ON TUBERCULOSIS INFECTION TESTING MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Tuberculosis infection testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Tuberculosis infection testing market are anticipated to lucrative growth opportunities in the future with the rising demand for Tuberculosis infection testing in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Tuberculosis infection testing market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
  •  Danaher
  •  Becton Dickinson
  •  Bio-Rad
  •  Qiagen
  •  Thermo Fisher Scientific
  •  Roche
  •  Oxford Immunotec
  •  Hologic
  •  Hain Lifescience
  •  Genedrive plc
    The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


    Get more information on this report :

  • TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Tuberculosis Infection Testing Market - By Type
    1.3.2 Tuberculosis Infection Testing Market - By End Use
    1.3.3 Tuberculosis Infection Testing Market - By Region
    1.3.3.1 By Country
    2. KEY TAKEAWAYS
    3. RESEARCH METHODOLOGY
    4. TUBERCULOSIS INFECTION TESTING MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PEST ANALYSIS
    4.2.1 North America - Pest Analysis
    4.2.2 Europe - Pest Analysis
    4.2.3 Asia-Pacific - Pest Analysis
    4.2.4 Middle East and Africa - Pest Analysis
    4.2.5 South and Central America - Pest Analysis
    4.3. EXPERT OPINIONS
    5. TUBERCULOSIS INFECTION TESTING MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
    6. TUBERCULOSIS INFECTION TESTING MARKET - GLOBAL MARKET ANALYSIS
    6.1. TUBERCULOSIS INFECTION TESTING - GLOBAL MARKET OVERVIEW
    6.2. TUBERCULOSIS INFECTION TESTING - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING
    7. TUBERCULOSIS INFECTION TESTING MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
    7.1. OVERVIEW
    7.2. TYPE MARKET FORECASTS AND ANALYSIS
    7.3. TUBERCULIN SKIN TEST (TST)
    7.3.1. Overview
    7.3.2. Tuberculin Skin Test (TST) Market Forecast and Analysis
    7.4. INTERFERON GAMMA RELEASED ASSAY (IGRA)
    7.4.1. Overview
    7.4.2. Interferon Gamma Released Assay (IGRA) Market Forecast and Analysis
    7.5. OTHERS
    7.5.1. Overview
    7.5.2. Others Market Forecast and Analysis
    8. TUBERCULOSIS INFECTION TESTING MARKET - REVENUE AND FORECASTS TO 2028 - END USE
    8.1. OVERVIEW
    8.2. END USE MARKET FORECASTS AND ANALYSIS
    8.3. HOSPITALS AND CLINICS
    8.3.1. Overview
    8.3.2. Hospitals and Clinics Market Forecast and Analysis
    8.4. DIAGNOSTIC LABORATORIES
    8.4.1. Overview
    8.4.2. Diagnostic Laboratories Market Forecast and Analysis
    8.5. OTHERS
    8.5.1. Overview
    8.5.2. Others Market Forecast and Analysis
    9. TUBERCULOSIS INFECTION TESTING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    9.1. NORTH AMERICA
    9.1.1 North America Tuberculosis Infection Testing Market Overview
    9.1.2 North America Tuberculosis Infection Testing Market Forecasts and Analysis
    9.1.3 North America Tuberculosis Infection Testing Market Forecasts and Analysis - By Type
    9.1.4 North America Tuberculosis Infection Testing Market Forecasts and Analysis - By End Use
    9.1.5 North America Tuberculosis Infection Testing Market Forecasts and Analysis - By Countries
    9.1.5.1 United States Tuberculosis Infection Testing Market
    9.1.5.1.1 United States Tuberculosis Infection Testing Market by Type
    9.1.5.1.2 United States Tuberculosis Infection Testing Market by End Use
    9.1.5.2 Canada Tuberculosis Infection Testing Market
    9.1.5.2.1 Canada Tuberculosis Infection Testing Market by Type
    9.1.5.2.2 Canada Tuberculosis Infection Testing Market by End Use
    9.1.5.3 Mexico Tuberculosis Infection Testing Market
    9.1.5.3.1 Mexico Tuberculosis Infection Testing Market by Type
    9.1.5.3.2 Mexico Tuberculosis Infection Testing Market by End Use
    9.2. EUROPE
    9.2.1 Europe Tuberculosis Infection Testing Market Overview
    9.2.2 Europe Tuberculosis Infection Testing Market Forecasts and Analysis
    9.2.3 Europe Tuberculosis Infection Testing Market Forecasts and Analysis - By Type
    9.2.4 Europe Tuberculosis Infection Testing Market Forecasts and Analysis - By End Use
    9.2.5 Europe Tuberculosis Infection Testing Market Forecasts and Analysis - By Countries
    9.2.5.1 Germany Tuberculosis Infection Testing Market
    9.2.5.1.1 Germany Tuberculosis Infection Testing Market by Type
    9.2.5.1.2 Germany Tuberculosis Infection Testing Market by End Use
    9.2.5.2 France Tuberculosis Infection Testing Market
    9.2.5.2.1 France Tuberculosis Infection Testing Market by Type
    9.2.5.2.2 France Tuberculosis Infection Testing Market by End Use
    9.2.5.3 Italy Tuberculosis Infection Testing Market
    9.2.5.3.1 Italy Tuberculosis Infection Testing Market by Type
    9.2.5.3.2 Italy Tuberculosis Infection Testing Market by End Use
    9.2.5.4 Spain Tuberculosis Infection Testing Market
    9.2.5.4.1 Spain Tuberculosis Infection Testing Market by Type
    9.2.5.4.2 Spain Tuberculosis Infection Testing Market by End Use
    9.2.5.5 United Kingdom Tuberculosis Infection Testing Market
    9.2.5.5.1 United Kingdom Tuberculosis Infection Testing Market by Type
    9.2.5.5.2 United Kingdom Tuberculosis Infection Testing Market by End Use
    9.2.5.6 Rest of Europe Tuberculosis Infection Testing Market
    9.2.5.6.1 Rest of Europe Tuberculosis Infection Testing Market by Type
    9.2.5.6.2 Rest of Europe Tuberculosis Infection Testing Market by End Use
    9.3. ASIA-PACIFIC
    9.3.1 Asia-Pacific Tuberculosis Infection Testing Market Overview
    9.3.2 Asia-Pacific Tuberculosis Infection Testing Market Forecasts and Analysis
    9.3.3 Asia-Pacific Tuberculosis Infection Testing Market Forecasts and Analysis - By Type
    9.3.4 Asia-Pacific Tuberculosis Infection Testing Market Forecasts and Analysis - By End Use
    9.3.5 Asia-Pacific Tuberculosis Infection Testing Market Forecasts and Analysis - By Countries
    9.3.5.1 Australia Tuberculosis Infection Testing Market
    9.3.5.1.1 Australia Tuberculosis Infection Testing Market by Type
    9.3.5.1.2 Australia Tuberculosis Infection Testing Market by End Use
    9.3.5.2 China Tuberculosis Infection Testing Market
    9.3.5.2.1 China Tuberculosis Infection Testing Market by Type
    9.3.5.2.2 China Tuberculosis Infection Testing Market by End Use
    9.3.5.3 India Tuberculosis Infection Testing Market
    9.3.5.3.1 India Tuberculosis Infection Testing Market by Type
    9.3.5.3.2 India Tuberculosis Infection Testing Market by End Use
    9.3.5.4 Japan Tuberculosis Infection Testing Market
    9.3.5.4.1 Japan Tuberculosis Infection Testing Market by Type
    9.3.5.4.2 Japan Tuberculosis Infection Testing Market by End Use
    9.3.5.5 South Korea Tuberculosis Infection Testing Market
    9.3.5.5.1 South Korea Tuberculosis Infection Testing Market by Type
    9.3.5.5.2 South Korea Tuberculosis Infection Testing Market by End Use
    9.3.5.6 Indonesia Tuberculosis Infection Testing Market
    9.3.5.6.1 Indonesia Tuberculosis Infection Testing Market by Type
    9.3.5.6.2 Indonesia Tuberculosis Infection Testing Market by End Use
    9.3.5.7 Rest of Asia-Pacific Tuberculosis Infection Testing Market
    9.3.5.7.1 Rest of Asia-Pacific Tuberculosis Infection Testing Market by Type
    9.3.5.7.2 Rest of Asia-Pacific Tuberculosis Infection Testing Market by End Use
    9.4. MIDDLE EAST AND AFRICA
    9.4.1 Middle East and Africa Tuberculosis Infection Testing Market Overview
    9.4.2 Middle East and Africa Tuberculosis Infection Testing Market Forecasts and Analysis
    9.4.3 Middle East and Africa Tuberculosis Infection Testing Market Forecasts and Analysis - By Type
    9.4.4 Middle East and Africa Tuberculosis Infection Testing Market Forecasts and Analysis - By End Use
    9.4.5 Middle East and Africa Tuberculosis Infection Testing Market Forecasts and Analysis - By Countries
    9.4.5.1 South Africa Tuberculosis Infection Testing Market
    9.4.5.1.1 South Africa Tuberculosis Infection Testing Market by Type
    9.4.5.1.2 South Africa Tuberculosis Infection Testing Market by End Use
    9.4.5.2 Saudi Arabia Tuberculosis Infection Testing Market
    9.4.5.2.1 Saudi Arabia Tuberculosis Infection Testing Market by Type
    9.4.5.2.2 Saudi Arabia Tuberculosis Infection Testing Market by End Use
    9.4.5.3 U.A.E Tuberculosis Infection Testing Market
    9.4.5.3.1 U.A.E Tuberculosis Infection Testing Market by Type
    9.4.5.3.2 U.A.E Tuberculosis Infection Testing Market by End Use
    9.4.5.4 Rest of Middle East and Africa Tuberculosis Infection Testing Market
    9.4.5.4.1 Rest of Middle East and Africa Tuberculosis Infection Testing Market by Type
    9.4.5.4.2 Rest of Middle East and Africa Tuberculosis Infection Testing Market by End Use
    9.5. SOUTH AND CENTRAL AMERICA
    9.5.1 South and Central America Tuberculosis Infection Testing Market Overview
    9.5.2 South and Central America Tuberculosis Infection Testing Market Forecasts and Analysis
    9.5.3 South and Central America Tuberculosis Infection Testing Market Forecasts and Analysis - By Type
    9.5.4 South and Central America Tuberculosis Infection Testing Market Forecasts and Analysis - By End Use
    9.5.5 South and Central America Tuberculosis Infection Testing Market Forecasts and Analysis - By Countries
    9.5.5.1 Brazil Tuberculosis Infection Testing Market
    9.5.5.1.1 Brazil Tuberculosis Infection Testing Market by Type
    9.5.5.1.2 Brazil Tuberculosis Infection Testing Market by End Use
    9.5.5.2 Argentina Tuberculosis Infection Testing Market
    9.5.5.2.1 Argentina Tuberculosis Infection Testing Market by Type
    9.5.5.2.2 Argentina Tuberculosis Infection Testing Market by End Use
    9.5.5.3 Rest of South and Central America Tuberculosis Infection Testing Market
    9.5.5.3.1 Rest of South and Central America Tuberculosis Infection Testing Market by Type
    9.5.5.3.2 Rest of South and Central America Tuberculosis Infection Testing Market by End Use
    10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL TUBERCULOSIS INFECTION TESTING MARKET
    10.1 North America
    10.2 Europe
    10.3 Asia-Pacific
    10.4 Middle East and Africa
    10.5 South and Central America
    11. INDUSTRY LANDSCAPE
    11.1. MERGERS AND ACQUISITIONS
    11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    11.3. NEW PRODUCT LAUNCHES
    11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
    12. TUBERCULOSIS INFECTION TESTING MARKET, KEY COMPANY PROFILES
    12.1. DANAHER
    12.1.1. Key Facts
    12.1.2. Business Description
    12.1.3. Products and Services
    12.1.4. Financial Overview
    12.1.5. SWOT Analysis
    12.1.6. Key Developments
    12.2. BECTON DICKINSON
    12.2.1. Key Facts
    12.2.2. Business Description
    12.2.3. Products and Services
    12.2.4. Financial Overview
    12.2.5. SWOT Analysis
    12.2.6. Key Developments
    12.3. BIO-RAD
    12.3.1. Key Facts
    12.3.2. Business Description
    12.3.3. Products and Services
    12.3.4. Financial Overview
    12.3.5. SWOT Analysis
    12.3.6. Key Developments
    12.4. QIAGEN
    12.4.1. Key Facts
    12.4.2. Business Description
    12.4.3. Products and Services
    12.4.4. Financial Overview
    12.4.5. SWOT Analysis
    12.4.6. Key Developments
    12.5. THERMO FISHER SCIENTIFIC
    12.5.1. Key Facts
    12.5.2. Business Description
    12.5.3. Products and Services
    12.5.4. Financial Overview
    12.5.5. SWOT Analysis
    12.5.6. Key Developments
    12.6. ROCHE
    12.6.1. Key Facts
    12.6.2. Business Description
    12.6.3. Products and Services
    12.6.4. Financial Overview
    12.6.5. SWOT Analysis
    12.6.6. Key Developments
    12.7. OXFORD IMMUNOTEC
    12.7.1. Key Facts
    12.7.2. Business Description
    12.7.3. Products and Services
    12.7.4. Financial Overview
    12.7.5. SWOT Analysis
    12.7.6. Key Developments
    12.8. HOLOGIC
    12.8.1. Key Facts
    12.8.2. Business Description
    12.8.3. Products and Services
    12.8.4. Financial Overview
    12.8.5. SWOT Analysis
    12.8.6. Key Developments
    12.9. HAIN LIFESCIENCE
    12.9.1. Key Facts
    12.9.2. Business Description
    12.9.3. Products and Services
    12.9.4. Financial Overview
    12.9.5. SWOT Analysis
    12.9.6. Key Developments
    12.10. GENEDRIVE PLC
    12.10.1. Key Facts
    12.10.2. Business Description
    12.10.3. Products and Services
    12.10.4. Financial Overview
    12.10.5. SWOT Analysis
    12.10.6. Key Developments
    13. APPENDIX
    13.1. ABOUT THE INSIGHT PARTNERS
    13.2. GLOSSARY OF TERMS
    The List of Companies

    1. Danaher
    2. Becton Dickinson
    3. Bio-Rad
    4. Qiagen
    5. Thermo Fisher Scientific
    6. Roche
    7. Oxford Immunotec
    8. Hologic
    9. Hain Lifescience
    10. Genedrive plc
    11. Akonni Biosystems
    12. Creative Diagnostics
    TIPRE00024196
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Pricing

    Free

    20%

    customization on Pre-Booking
    Request for Sample
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.